1-9 of 9
Julie R. Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B020: Improved outcome for patients with alternative lengthening of telomeres (ALT) neuroblastoma randomized to tandem myeloablative therapy on COG ANBL0532

Free
Balakrishna Koneru, Trevor Burrow, Kristyn McCoy, Jonas Nance, Arlene Naranjo, Fan F. Zhang, Meredith S. Irwin, Julie R. Park, C. Patrick Reynolds
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement): B020.
https://doi.org/10.1158/1538-7445.PEDIATRIC24-B020
Published: 05 September 2024
View articletitled, Abstract B020: Improved outcome for patients with alternative lengthening of telomeres (ALT) neuroblastoma randomized to tandem myeloablative therapy on COG ANBL0532
Journal Articles

Abstract LB121: BrainChild-03: Intraventricular B7-H3 CAR T cells for recurrent/refractory central nervous system tumors and non-pontine diffuse midline glioma in children and young adults

Free
Nicholas A. Vitanza, Juliane Gust, Rebecca Ronsley, Ashley L. Wilson, Wenjun Huang, Kristy Seidel, Catherine M. Albert, Navin Pinto, Rimas J. Orentas, Rebecca A. Gardner, Michael C. Jensen, Julie R. Park
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB121.
https://doi.org/10.1158/1538-7445.AM2023-LB121
Published: 14 April 2023
View articletitled, Abstract LB121: BrainChild-03: Intraventricular B7-H3 CAR T cells for recurrent/refractory central nervous system tumors and non-pontine diffuse midline glioma in children and young adults
Journal Articles

Abstract CT137: ENLIGHTen-01: a phase 1 study of fluorescein-specific (FITC-E2)-car T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma

Free
Catherine M. Albert, Navin R. Pinto, Mallory Taylor, Ashley Wilson, Stephanie Rawlings-Rhea, Prabha Narayanaswamy, Wenjun Huang, Kristy Seidel, Stephanie Mgebroff, Christopher Brown, Jacob Garcia, Jeffrey Teoh, Rimas J. Orentas, Rebecca A. Gardner, Michael C. Jensen, Julie R. Park
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT137.
https://doi.org/10.1158/1538-7445.AM2023-CT137
Published: 14 April 2023
View articletitled, Abstract CT137: ENLIGHTen-01: a phase 1 study of fluorescein-specific (FITC-E2)-car T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma
Journal Articles

Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers

Free
Adam J. Wolpaw, Richard Bayliss, Gabriele Büchel, Chi V. Dang, Martin Eilers, W. Clay Gustafson, Gwenn H. Hansen, Natalia Jura, Stefan Knapp, Mark A. Lemmon, David Levens, John M. Maris, Ronen Marmorstein, Steven J. Metallo, Julie R. Park, Linda Z. Penn, Michael Rape, Martine F. Roussel, Kevan M. Shokat, William P. Tansey, Kliment A. Verba, Seychelle M. Vos, William A. Weiss, Elmar Wolf, Yaël P. Mossé
Journal: Cancer Research
Series: Author Choice
Cancer Res (2021) 81 (7): 1627–1632.
https://doi.org/10.1158/0008-5472.CAN-20-3108
Published: 01 April 2021
View articletitled, Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Open the PDF for Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers in another window
Journal Articles

Abstract B67: EGFR as a target in pediatric solid tumors

Free
Catherine M. Albert, Navin R. Pinto, Erin R. Rudzinski, Julie R. Park
Journal: Cancer Research
Cancer Res (2020) 80 (14_Supplement): B67.
https://doi.org/10.1158/1538-7445.PEDCA19-B67
Published: 15 July 2020
View articletitled, Abstract B67: EGFR as a target in pediatric solid tumors
Journal Articles

Abstract LB-049: Low plasma levels of 13-cis-retinoic acid (isotretinoin) and its active metabolite 4-oxo-13-cis-retinoic acid are associated with lower overall survival of high-risk neuroblastoma patients

Free
Hwangeui Cho, Arlene Naranjo, Collin Van Ryn, Shengping Yang, Poonam Sonawane, Judith G. Villablanca, Alice L. You, Julie R. Park, Susan Kreissman, C Patrick Reynolds, Min H. Kang
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-049.
https://doi.org/10.1158/1538-7445.AM2017-LB-049
Published: 01 July 2017
View articletitled, Abstract LB-049: Low plasma levels of 13-cis-retinoic acid (isotretinoin) and its active metabolite 4-oxo-13-cis-retinoic acid are associated with lower overall survival of high-risk neuroblastoma patients
Journal Articles

Abstract LB-048: Impact of KIR/KIR ligand genotype for neuroblastoma patients in a Phase 3 COG immunotherapy trial

Free
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Patrick K. Reville, Wendy B. London, Jacquelyn A. Hank, Mitchell B. Diccianni, Arlene Naranjo, Michael Hogarty, Julie R. Park, Alice L. Yu, Paul M. Sondel
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-048.
https://doi.org/10.1158/1538-7445.AM2017-LB-048
Published: 01 July 2017
View articletitled, Abstract LB-048: Impact of KIR/KIR ligand genotype for neuroblastoma patients in a Phase 3 COG immunotherapy trial
Journal Articles

Abstract B40: MYCN/MYC protein expression in high-MKI (Mitosis-Karyorrhexis Index) neuroblastomas: A report from the Children's Oncology Group

Free
Larry L. Wang, Risa Teshiba, Lejian He, Arlene Naranjo, Wendy B. London, Julie M. Gastier-Foster, Robert C. Seeger, Susan L. Cohn, John M. Maris, Julie R. Park, Michael D. Hogarty, Hiroyuki Shimada
Journal: Cancer Research
Cancer Res (2014) 74 (20_Supplement): B40.
https://doi.org/10.1158/1538-7445.PEDCAN-B40
Published: 09 October 2014
View articletitled, Abstract B40: MYCN/MYC protein expression in high-MKI (Mitosis-Karyorrhexis Index) neuroblastomas: A report from the Children's Oncology Group
Journal Articles

Abstract 5139: Therapeutic targets for neuroblastoma by genome scale siRNA screens

Free
Heather Howie, Masafumi Toyoshima, James E. Annis, Lauren Richard, Julie R. Park, Carla Grandori
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5139.
https://doi.org/10.1158/1538-7445.AM2012-5139
Published: 15 April 2012
View articletitled, Abstract 5139: Therapeutic targets for neuroblastoma by genome scale siRNA screens